Pharma Virtual 360° Tour of Wacker Biotech’s GMP Production Facilities in Jena and Halle

EUROPE (BURGHAUSEN)
Webinar | Customers

Description

A Virtual 360° Tour of Wacker Biotech’s GMP Facilities in Jena and Halle

Requirements

not relevant

Agenda

  • About Wacker Biotech
  • A virtual tour in Jena
  • A virtual tour in Halle
  • Q&A

Seminar objectives

In this webinar, Marco Wolf and Markus Barth will lead you in a virtual tour through our GMP production facilities in Jena and Halle.

With over 20 years of experience producing microbial derived proteins and vaccines, Wacker Biotech is a world-leading partner when it comes to manufacturing microbial biopharmaceuticals for our customers.

Our production lines in Jena and Halle (Germany) are equipped with stainless steel fermentation vessels from 350 to 1,500 liter. Corresponding primary recovery, downstream and Fill & Finish capabilities are available to suit various customer needs along the development path.

Enjoy a 360° panoramic tour of our state-of-the-art EMA/FDA-certified GMP facilities – right from your desk.

Target audience

Biopharma representatives

Seminar language

English

Fee (includes value-added tax)

0.00 EUR

Number of participants

1 - 500

Trainer

Marco Wolf

Marco Wolf is Wacker Biotech GmbH's Head of Production for the Jena site. Marco is a trained biotechnology engineer and completed the qualification of Master of Business Administration. He has more than 13 years of experience in the large-scale production of various biopharmaceuticals under GMP conditions.

Markus Barth

Markus Barth, PhD, is Head of Production for the Halle facility of Wacker Biotech. Markus is a trained bioengineer and biochemist. Within more than 7 years he has gained significant experience in the large-scale production under GMP conditions of various biopharmaceuticals using mammalian cells and bacteria.